USFDA grants VAI classification to Dr Reddy's R&D centre

Dr Reddy's Laboratories announced that its Hyderabad-based R&D centre has received Voluntary Action Indicated (VAI) classification from the US FDA after an inspection. This classification indicates that objectionable conditions or practices were found, but no further administrative or regulatory action is required.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news